Form 10-Q Cellectar Biosciences, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cellectar Biosciences (CLRB) Reports Q1 Loss of $0.30/Share
May 21, 2015 4:17 PM EDTCellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.30), versus ($1.03) reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
... More